Endymed
Endymed Ltd provides energy based medical aesthetic treatment systems for the professional and consumer markets in North America, Europe, the Middle East, Africa, Asia, Oceania, Latin America, and internationally. The company offers ENDYMED PRO, an all-in-one treatment platform; ENDYMED PURE 2.0, a compact and flexible treatment platform; Pure Laser, a laser hair removal system; Intensif, a RF mi… Read more
Endymed (ENDY) - Total Liabilities
Latest total liabilities as of September 2024: ILA4.96 Million ILA
Based on the latest financial reports, Endymed (ENDY) has total liabilities worth ILA4.96 Million ILA as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Endymed - Total Liabilities Trend (2008–2023)
This chart illustrates how Endymed's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Endymed Competitors by Total Liabilities
The table below lists competitors of Endymed ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Piscines Jean Desjoyaux
BE:DJX
|
Germany | €66.97 Million |
|
STRAIT MINERALS
F:S5G
|
Germany | €1.30 Million |
|
PENN NATL GAMING
BE:PN1
|
Germany | €12.45 Billion |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
USA | $1.59 Billion |
|
Targeted Microwave Solutions Inc
PINK:TGTMF
|
USA | $466.41K |
Liability Composition Analysis (2008–2023)
This chart breaks down Endymed's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Endymed's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Endymed (2008–2023)
The table below shows the annual total liabilities of Endymed from 2008 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ILA5.22 Million | +4.47% |
| 2022-12-31 | ILA4.99 Million | -14.46% |
| 2021-12-31 | ILA5.84 Million | +14.90% |
| 2020-12-31 | ILA5.08 Million | -14.30% |
| 2019-12-31 | ILA5.93 Million | +10.82% |
| 2018-12-31 | ILA5.35 Million | -28.98% |
| 2017-12-31 | ILA7.53 Million | +18.56% |
| 2016-12-31 | ILA6.35 Million | +16.61% |
| 2015-12-31 | ILA5.45 Million | -75.41% |
| 2014-12-31 | ILA22.15 Million | +118.57% |
| 2013-12-31 | ILA10.13 Million | +6.20% |
| 2012-12-31 | ILA9.54 Million | +258.36% |
| 2011-12-31 | ILA2.66 Million | -47.09% |
| 2010-12-31 | ILA5.03 Million | -35.00% |
| 2009-12-31 | ILA7.74 Million | +22.81% |
| 2008-12-31 | ILA6.30 Million | -- |